About the medication safety. Pharmacovigilance Polska 2025 Congress

Opublikowano:
SA lecture hall with red chairs, a stage with white armchairs, and a projection screen. On the right wall, there are portraits in red frames. The participants are focused on the presentation.
The experts met to discuss the latest regulations, technological innovations, and best practices in pharmacovigilance.

On October 21, 2025, the PHARMACOVIGILANCE Poland 2025 Congress was held at the Teaching Center WUM, bringing together representatives of various medical professions, experts from the pharmaceutical industry, representatives of regulatory authorities, and the scientific community. The main theme of this year's meeting was the challenges facing the drug safety monitoring system. Panelists from Poland and abroad exchanged experiences and proposed solutions to pressing problems in this area.

Over 350 participants had the opportunity to listen to extremely interesting lectures and take part in expert debates on the latest legal regulations, innovative technologies supporting the monitoring of pharmacotherapy safety, and optimal practices in the field of pharmacovigilance.

The topics discussed during the congress are not only inspiring for the scientific community, regulatory authorities, responsible companies, and medical personnel, but most importantly for patients. Patient medication safety means minimizing the risks associated with the use of medicines and promoting good habits related to pharmacotherapy, so that it is not only effective but also safe. Patient awareness of the potential side effects of medicines and their right to report suspected adverse drug reactions are crucial for all of us. One of the important themes that emerged during the conference was the provision of optimal undergraduate and postgraduate education.

The event was organized by the Polish Society for Safe Therapy, the Medical University of Warsaw, and the Association of Innovative Pharmaceutical Companies INFARMA.

The employees of the Medical University of Warsaw involved in organizing the Congress were:

  • Prof. Dagmara Mirowska-Guzel, Head of the Department of Experimental and Clinical Pharmacology, was a member of the Scientific Committee of the Congress. She participated in the opening of the Congress, gave a lecture entitled “The use of aRMM in clinical practice: theory and experience,” and took part in two expert debates: “Additional risk minimization measures (aRMM)” and “National pharmacotherapy safety monitoring system – challenges of the coming decade”; Prof. Adam Przybyłkowski, Head of the Department of Gastroenterology and Internal Diseases, who gave a lecture entitled “Patient safety from the EMA perspective” and took part in the discussion panel “The present and future of Pharmacovigilance – global and Polish trends”;
  • Prof. Anna Staniszewska from the Department of Experimental and Clinical Pharmacology participated as the moderator of the expert panel “National pharmacotherapy safety monitoring system – challenges for the coming decade”;
  • Other lecturers included Magdalena Niedzielko, MA, from the Department of Experimental and Clinical Pharmacology, who gave a lecture entitled “Knowledge and beliefs about drug safety monitoring in the Polish population,” and Dr. Marcin Podgórski from the Department of Emergency Medical Services (director of the Polish Medical Air Rescue), who gave a lecture entitled “Adverse drug reactions in the practice of a paramedic.”
    The event was also attended by Prof. Marcin Czech, Undersecretary of State at the Ministry of Health in 2017-2019, who had been associated with our university for many years.

In addition to the honorary patronage granted by the Rector of the Medical University of Warsaw, Prof. Rafał Krenke, and the president of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Dr. Grzegorz Cesska, the event was also sponsored by: the Patient Ombudsman, the Supreme Medical Chamber, the Supreme Pharmaceutical Chamber, the Supreme Council of Nurses and Midwives, the Polish Association of Self-Medication Industry (PASMI), the Committee on Therapy and Drug Sciences of the Polish Academy of Sciences, the Polish Society of Clinical Pharmacology and Therapy, the Polish Society of Pharmacoeconomics, the Polish Pharmaceutical Society, the Polish Pharmacological Society, the National Consultant in Clinical Pharmacy, the National Consultant in Clinical Pharmacology, and the “Obywatele Zdrowo Zaangażowani” Foundation.

A woman and a man are sitting next to each other on red chairs during a conference. The man is wearing a suit and a name tag, while the woman is wearing a light-colored dress with black patterns and glasses. Other participants are visible in the background.
A person in a navy blue outfit with an ID badge stands in front of a window and presents the content visible on the screen.
A group of people in business attire are seated in rows of wooden chairs in a lecture hall. Some of them have ID badges on lanyards. There is a window on the right-hand side.
A group of people are sitting on red chairs in a conference room. In the foreground, an older man in a suit and red sweater is looking at the camera. Some participants are clapping.
A man in a suit stands on stage with a microphone. In the background, there is a banner with the logo and name “ptbfarm” and the text “Polish Society for Safe Pharmacotherapy.” On stage, there are white armchairs and tables with bottles of water.
A person is giving a presentation in a lecture hall. A slide about pharmacotherapy in emergency medical services is visible on the screen. The audience is seated in the foreground.